Werewolf Therapeutics, Inc. announced the appointment of Mike Sherman, chief executive officer of Chimerix, Inc., as a member of its board of directors. Mr. Sherman joins the Werewolf board of directors with more than 30 years’ experience in the biotechnology and medical technology industries. He is currently Chief Executive Officer of Chimerix. Before joining Chimerix, he served as Chief Executive Officer of Endocyte, Inc.